Research suggests that Triphala may support digestive health in part by acting as a prebiotic, favorably shifting the composition of gut bacteria in ways that could benefit the host. The available evidence comes from a single in vitro study published in 2018, which used human fecal cultures rather than live human subjects, finding that Triphala increased the relative abundance of beneficial bacteria such as Bifidobacterium and Lactobacillus while reducing potential pathogens like Klebsiella pneumoniae. The study also found indications that Triphala may promote bacteria associated with short-chain fatty acid production, compounds linked to gut health. However, the evidence base is currently very limited, consisting of laboratory work only, and findings from fecal culture models do not necessarily translate to effects in the living human gut, so further clinical research would be needed to draw stronger conclusions.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Prebiotic Potential of Herbal Medicines Used in Digestive Health and Disease. | Other | 2018 | Supports | 100 |